Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Manuel Dómine Gómez"'
Autor:
Benito Farina, Ana Delia Ramos Guerra, David Bermejo-Peláez, Carmelo Palacios Miras, Andrés Alcazar Peral, Guillermo Gallardo Madueño, Jesús Corral Jaime, Anna Vilalta-Lacarra, Jaime Rubio Pérez, Arrate Muñoz-Barrutia, German R. Peces-Barba, Luis Seijo Maceiras, Ignacio Gil-Bazo, Manuel Dómine Gómez, María J. Ledesma-Carbayo
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-15 (2023)
Abstract Background Identifying predictive non-invasive biomarkers of immunotherapy response is crucial to avoid premature treatment interruptions or ineffective prolongation. Our aim was to develop a non-invasive biomarker for predicting immunothera
Externí odkaz:
https://doaj.org/article/399bc1686fc84f0fbfd92c6c8452620b
Autor:
Estela Sánchez‐Herrero, Roberto Serna‐Blasco, Vadym Ivanchuk, Rosario García‐Campelo, Manuel Dómine Gómez, José M. Sánchez, Bartomeu Massutí, Noemi Reguart, Carlos Camps, Sandra Sanz‐Moreno, Silvia Calabuig‐Fariñas, Eloísa Jantus‐Lewintre, Magdalena Arnal, Dietmar Fernández‐Orth, Virginia Calvo, Víctor González‐Rumayor, Mariano Provencio, Atocha Romero
Publikováno v:
Molecular Oncology, Vol 15, Iss 9, Pp 2363-2376 (2021)
Despite impressive and durable responses, nonsmall cell lung cancer (NSCLC) patients treated with anaplastic lymphoma kinase (ALK) inhibitors (ALK‐Is) ultimately progress due to development of resistance. Here, we have evaluated the clinical utilit
Externí odkaz:
https://doaj.org/article/f8857d8e937348c0ac60929a958c48fe
Autor:
Manuel Dómine Gómez, Tibor Csőszi, Rajesh K. Malik, Krasimir Nikolov, Iveta Kudaba, Davorin Radosavljevic, Jana Jaal, Janet K. Horton, Jie Xiao, Janakiraman Subramanian
Publikováno v:
International Journal of Cancer
Chemotherapy-induced myelosuppression is an acute, dose-limiting toxicity of chemotherapy regimens used in the treatment of extensive-stage small cell lung cancer (ES-SCLC). Trilaciclib protects haematopoietic stem and progenitor cells from chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::397a1ab260b5397a4563aa20f7c067be
http://europepmc.org/articles/PMC8457063
http://europepmc.org/articles/PMC8457063
Autor:
Jaime Rubio-Perez, Ángel Ricardo Rodríguez-Perez, María Díaz-Blázquez, Victor Moreno-García, Manuel Dómine-Gómez
Publikováno v:
Journal of medical case reports. 16(1)
Background Immune checkpoint inhibitors avoid inhibition of T-cell responses, upregulating antitumor immune response. Moreover, a dysregulation with hyperactive immune response can be caused, some of them underdiagnosed. Hemophagocytic lymphohistiocy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d49b6005c5aafdae31f183f4b2cc3b9
https://pubmed.ncbi.nlm.nih.gov/36195892
https://pubmed.ncbi.nlm.nih.gov/36195892
Autor:
Emilio Esteban González, Raúl Poza de Celis, Manuel Dómine Gómez, Susana Traseira Lugilde, Blanca Cantos Sánchez de Ibargüen, Jaume Capdevila Castillón, Ignacio Peláez Fernández, Rafael Trujillo Vílchez, Luis Zugazabeitia Olabarría, Joaquina Martínez Lozano, Nieves Fernandez
Publikováno v:
Advances in Therapy. 34:136-147
Bone metastasis is the most common cause of cancer-related pain, and metastatic bone pain (MBP) is not only severe but also progressive in many patients. The aim of this study was to investigate the association between pain management and performance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9549df31f72dcbd23b12b74f003d565c
https://doi.org/10.1007/s12325-016-0435-1
https://doi.org/10.1007/s12325-016-0435-1
Autor:
Emmett Schmidt, Jonathan Thompson, Michael Chisamore, James Spicer, Åslaug Helland, Edurne Arriola, Manuel Dómine Gomez, Jose Manuel Trigo Perez, Ana Laura Ortega Granados, Noelly Madeleine, Austin Rayford, Katherine Lorens, Abdul Siddiqui, Hani Gabra, Jaya Nautiyal, David Micklem, James Lorens
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/ae2b9c922e2e4cff96ff5a8879f3632b
Autor:
Jaime Rubio-Perez, Ángel Ricardo Rodríguez-Perez, María Díaz-Blázquez, Victor Moreno-García, Manuel Dómine-Gómez
Publikováno v:
Journal of Medical Case Reports, Vol 16, Iss 1, Pp 1-7 (2022)
Abstract Background Immune checkpoint inhibitors avoid inhibition of T-cell responses, upregulating antitumor immune response. Moreover, a dysregulation with hyperactive immune response can be caused, some of them underdiagnosed. Hemophagocytic lymph
Externí odkaz:
https://doaj.org/article/2bdbdec0bb4d4f0ca971f418047aa2f4